Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial

Journal of Obstetrics and Gynaecology Canada

Volumn 38, Issue 8, 2016, Pages 723-726

  Smith, Laurie ^a   van Niekerk, Dirk ^a   Coldman, Andrew ^a,b   Krajden, Mel ^b,c   Franco, Eduardo L ^d   Ogilvie, Gina ^b,e  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e Women's Health Research Institute   (United States)

Author keywords

cervical cancer; HPV testing; screening program

Indexed keywords

WART VIRUS VACCINE;

CANADA; CANCER SCREENING; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; FOLLOW UP; HEALTH EDUCATION; HUMAN; MULTICENTER STUDY (TOPIC); NOTE; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; RESEARCH SUBJECT; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; EARLY CANCER DIAGNOSIS; FEMALE; ISOLATION AND PURIFICATION; MASS SCREENING; PROCEDURES; UTERINE CERVIX TUMOR; VIROLOGY;

EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; PAPANICOLAOU TEST; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84989822288     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jogc.2016.04.009     Document Type: Note

References (12)

1. 1 Dickinson, J.A., Stankiewicz, A., Popadiuk, C., Pogany, L., Onysko, J., Miller, A.B., Reduced cervical cancer incidence and mortality in Canada: national data from 1932-2006. BMC Public Health, 12, 2012, 992.
2. 2 Walboomers, J.M., Jacobs, M.V., Manos, M.M., Bosch, F.X., Kummer, J.A., Shah, K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999), 12–19.
3. 3 Munoz, N., Bosch, X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003), 518–527.
4. 4 Ronco, G., Dillner, J., Elfrstom, K., Tunesi, S., Snijders, P., Arbyn, M., et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383 (2014), 524–532.
5. 5 Wright, T.C., Stoler, M.H., Behrens, C.M., Sharma, A., Zhang, G., Wright, T.L., Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 136 (2015), 189–197.
6. 6 Ogilvie, G.S., van Niekerk, D.J., Krajden, M., Martin, R.E., Ehlen, T.G., Ceballos, K., et al. A randomized controlled trial of human papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer, 10, 2010, 111.
7. 7 Trottier, H., Franco, E., The epidemiology of genital human papillomavirus infection. Vaccine 24 (2006), S4–S15.
8. 8 Ogilvie, G.S., Smith, L.W., van Niekerk, D.J., Khurshed, F., Krajden, M., Saraiya, M., et al. Women's intentions to receive cervical cancer screening with human papillomavirus testing. Int J Cancer 133 (2013), 2934–2943.
9. 9 Daley, E., Perrin, K., McDermott, R., Vamos, C.A., Rayko, H.L., Packing-Ebuen, J.L., et al. The psychosocial burden of HPV. A mixed-method study of knowledge, attitudes, and behaviors among HPV+ women. J Health Psychol 15 (2010), 279–290.
10. 10 Ferenidou, F., Salakos, N., Vaidakis, N., Paltoglou, G., Bakalianou, K., Papadimitriou, G., et al. The impact of HPV diagnosis on women's sexual and mental health: preliminary findings. Clin Exp Obstet Gynecol 39 (2012), 79–82.
11. 11 McRae, J., Martin, C., O'Leary, J., Sharp, L., (Irish Cervical Screening Research Consortium [CERVIVA]). “If you can't treat HPV, why test for it?” Women's attitudes to the changing face of cervical cancer prevention: a focus group study. BMC Women's Health, 14, 2014, 64.
12. 12 McCaffery, K., Irwig, L., Australian women's needs and preferences for information about human papillomavirus in cervical screening. J Med Screen 12 (2005), 134–141.